Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
1.360
+0.050 (3.82%)
At close: Aug 29, 2025, 4:00 PM
1.355
-0.005 (-0.37%)
After-hours: Aug 29, 2025, 5:52 PM EDT

Acumen Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
82103222221274-
Upgrade
Market Cap Growth
-51.67%-53.53%0.62%-19.22%--
Upgrade
Enterprise Value
-57-126-602144-
Upgrade
Last Close Price
1.311.723.845.406.76-
Upgrade
PB Ratio
0.680.570.831.171.22-
Upgrade
P/TBV Ratio
0.680.570.831.171.22-
Upgrade
Debt / Equity Ratio
0.260.160.120.00--
Upgrade
Asset Turnover
-----0.06
Upgrade
Inventory Turnover
-729.95284.97229.51141.44114.24
Upgrade
Quick Ratio
5.796.2418.8122.7537.766.89
Upgrade
Current Ratio
5.976.4619.0123.0838.606.98
Upgrade
Return on Equity (ROE)
-75.71%-45.60%-22.98%-20.71%-76.44%-33.26%
Upgrade
Return on Assets (ROA)
-39.06%-25.96%-15.08%-13.25%-8.91%-19.11%
Upgrade
Return on Capital (ROIC)
-42.77%-27.97%-15.70%-13.66%-9.30%-22.46%
Upgrade
Earnings Yield
-172.89%-99.02%-23.55%-19.39%-36.77%-
Upgrade
FCF Yield
-149.09%-83.45%-19.38%-15.98%-6.58%-
Upgrade
Buyback Yield / Dilution
-3.87%-23.46%-19.72%-102.43%-4685.59%2.73%
Upgrade
Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q